Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Safety and Immunogenicity of Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Brief Summary: This study will assess safety and immunogenicity of GSK Biologicals' H5N1 flu candidate vaccine GSK1557484A in children 6 months to \< 18 years of age.


Options:
A: Arm Label: Influenza A (H5N1) adjuvanted 6-<36M Group; Type: EXPERIMENTAL; Interventions: Biological: Influenza A (H5N1) Virus monovalent vaccine | Arm Label: Influenza A (H5N1) Virus monovalent vaccine 3-<9Y Group; Type: EXPERIMENTAL; Interventions: Biological: Influenza A (H5N1) Virus monovalent vaccine | Arm Label: Influenza A (H5N1) Virus monovalent vaccine 9-<18Y Group; Type: EXPERIMENTAL; Interventions: Biological: Influenza A (H5N1) Virus monovalent vaccine | Arm Label: Placebo 6-<36M Group; Type: PLACEBO_COMPARATOR; Interventions: Biological: Saline placebo | Arm Label: Placebo 3-<9Y Group; Type: PLACEBO_COMPARATOR; Interventions: Biological: Saline placebo | Arm Label: Placebo 9-<18Y Group; Type: PLACEBO_COMPARATOR; Interventions: Biological: Saline placebo | Arm Label: Placebo/Influenza A (H5N1) adjuvanted Group; Type: EXPERIMENTAL; Interventions: Biological: Influenza A (H5N1) Virus monovalent vaccine | Intervention Type: BIOLOGICAL; Name: Influenza A (H5N1) Virus monovalent vaccine; Assigned to Arm(s): Influenza A (H5N1) Virus monovalent vaccine 3-<9Y Group, Influenza A (H5N1) Virus monovalent vaccine 9-<18Y Group, Influenza A (H5N1) adjuvanted 6-<36M Group, Placebo/Influenza A (H5N1) adjuvanted Group | Intervention Type: BIOLOGICAL; Name: Saline placebo; Assigned to Arm(s): Placebo 3-<9Y Group, Placebo 6-<36M Group, Placebo 9-<18Y Group
B: Arm Label: TIV-adj; Type: EXPERIMENTAL; Interventions: Biological: Adjuvanted trivalent inactivated subunit influenza vaccine | Arm Label: Flu-control; Type: ACTIVE_COMPARATOR; Interventions: Biological: Non-adjuvanted trivalent inactivated subunit influenza vaccine or non-adjuvanted trivalent inactivated split influenza vaccine | Arm Label: Non-flu Control; Type: SHAM_COMPARATOR; Interventions: Biological: Meningococcal C conjugate vaccine or tick-borne encephalitis vaccine | Intervention Type: BIOLOGICAL; Name: Adjuvanted trivalent inactivated subunit influenza vaccine; Assigned to Arm(s): TIV-adj | Intervention Type: BIOLOGICAL; Name: Non-adjuvanted trivalent inactivated subunit influenza vaccine or non-adjuvanted trivalent inactivated split influenza vaccine; Assigned to Arm(s): Flu-control | Intervention Type: BIOLOGICAL; Name: Meningococcal C conjugate vaccine or tick-borne encephalitis vaccine; Assigned to Arm(s): Non-flu Control
C: Intervention Type: DRUG; Name: Liquid CAIV-T; Assigned to Arm(s): N/A
D: Arm Label: Influenza vaccine LAIV; Type: EXPERIMENTAL; Interventions: Biological: Trivalent Inactivated Vaccine | Arm Label: Influenza vaccine TIV; Type: ACTIVE_COMPARATOR; Interventions: Biological: Live Attenuated Influenza Vaccine | Intervention Type: BIOLOGICAL; Name: Trivalent Inactivated Vaccine; Assigned to Arm(s): Influenza vaccine LAIV | Intervention Type: BIOLOGICAL; Name: Live Attenuated Influenza Vaccine; Assigned to Arm(s): Influenza vaccine TIV

Answer: A